 She has focussed on immuno-oncology in melanoma and targeted therapies.She also developed and is in charge of the treat-excise-analyse-melanoma (TEAM) program, which works on mechanisms of drug sensitivity and resistance.‘Hardly a week goes by without a melanoma patient or their family expressing their gratitude for Professor Long’s ground-breaking research and clinical trials which have afforded them or their loved ones valuable extra time, and in many cases, a new chance at life.